WYNNEFIELD CAPITAL INC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001251567
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 17 positions · Total reported value $222.49M · Top-10 concentration 97.4% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 12.5% · 0 new · 1 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -18.6% · vs SPY -20.7% · Prev Value $145.38M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +2.0% · vs SPY -0.1% · Latest Value $121.78M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, WYNNEFIELD CAPITAL INC disclosed 17 equity positions with a combined reported value of $222.49M. The filing implies a focused portfolio: its ten largest positions account for 97.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt.
The largest disclosed positions as of Q2 2024 were CDRE ($43.47M), DLHC ($38.88M), NATR ($37.28M). By sector, the heaviest allocations are Health Care 47.6%, Consumer Discretionary 18.0%. Versus the prior quarter, allocation shifted toward Materials (+3.1pp), Utilities (+1.5pp) and away from Other (-0.9pp), Health Care (-1.8pp).
Versus the prior quarter, WYNNEFIELD CAPITAL INC opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 12.5% of positions. The portfolio's overlap with the prior quarter was 74% of names.
Of the 6 positions fully exited versus the prior quarter, the largest were NOTVQ ($877.99K), APLS ($587.80K), LEAT ($92.75K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
No new positions this quarter.
Insider Transactions (Form 4)
Latest WYNNEFIELD CAPITAL INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Wynnefield Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 8 positions worth $121.78M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-73498 (status: Approved), registered 2012-03-30
- Regulatory AUM (Form ADV): $184.52M as of 2026-06-15
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 3 hedge funds
- Website: wynnefieldcapital.com
Portfolio Structure
- 8 positions · $121.78M reported value (Q3 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: LFCR (LIFECORE BIOMEDICAL INC) at 26.3%
- Average position size: $15.22M
Sector Tilt
- Health Care 76.9%
- Consumer Discretionary 11.2%
- Materials 5.3%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q3 2026: 1 added, 1 reduced
- 6 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.30M | $43.47M | 19.54% | Hold | |
| 2 |
|
3.68M | $38.88M | 17.47% | Hold | |
| 3 |
|
2.47M | $37.28M | 16.75% | Hold | |
| 4 |
|
490.00K | $32.05M | 14.40% | Hold | |
| 5 |
|
4.92M | $25.23M | 11.34% | Hold | |
| 6 |
|
2.73M | $24.06M | 10.81% | Hold | |
| 7 |
|
1.98M | $10.67M | 4.79% | Add | |
| 8 |
|
100.00K | $1.99M | 0.89% | Hold | |
| 9 |
|
400.00K | $1.61M | 0.72% | Hold | |
| 10 |
|
50.00K | $1.56M | 0.70% | Hold | |
| 11 |
|
4.25M | $1.53M | 0.69% | Hold | |
| 12 |
|
433.61K | $1.49M | 0.67% | Hold | |
| 13 |
|
446.03K | $1.10M | 0.49% | Hold | |
| 14 |
|
100.00K | $878.00K | 0.40% | Reduce | |
| 15 |
|
50.00K | $430.00K | 0.19% | Hold | |
| 16 |
|
50.95K | $197.18K | 0.09% | Hold | |
| 17 |
|
28.13K | $84.38K | 0.04% | Hold | |
FAQ
What did WYNNEFIELD CAPITAL INC buy in 2024-Q2?
In its 2024-Q2 13F filing, WYNNEFIELD CAPITAL INC reported 17 equity positions worth $222.49M in aggregate; its largest disclosed positions were CDRE ($43.47M), DLHC ($38.88M), NATR ($37.28M).
How large is WYNNEFIELD CAPITAL INC's portfolio?
WYNNEFIELD CAPITAL INC reported $222.49M of long equity holdings across 17 positions as of 2024-Q2. Top-10 holdings account for 97.4% of reported value.
What is WYNNEFIELD CAPITAL INC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.